News Category
Our Latest News
Koelis announces first procedures in 3D fusion imaging-guided focal ablation of prostate cancer in its clinical study VIOLETTE.
8 April, 2021FollowFollowFollowFollow Koelis announces first procedures in 3D fusion imaging-guided focal ablation of prostate cancer in its clinical study VIOLETTE. MEYLAN, France, April 8th, 2021 – KOELIS, an international leader in prostate fusion imaging, announces enrolling the first patients in the VIOLETTE clinical trial (NCT04582656) on 3D fusion imaging-guided focal ablation of prostate cancer. Prostate cancer […]
Read more >
KOELIS Announces Partnership with GMP
11 December, 2020KOELIS Announces Partnership with GMP, Providing VA Hospitals with Access to Advanced Prostate Care Technology KOELIS, Inc.
Read more >
KOELIS – Covid 19
20 March, 2020FollowFollowFollowFollow KOELIS Declaration about COVID-19 COVID-19 Measures and continuity at Koelis As all know, the World is hit by a health and economic pandemia.Koelis with offices and employees in France, USA, Hong Kong. We have customers, suppliers, partners, counsels, investors, on all continents. Today we want to express our absolute priority in protecting all of […]
Read more >
KOELIS & InnovaHealth Partners Partnership
11 September, 2019FollowFollowFollowFollow KOELIS & InnovaHealth Partnership KOELIS adventure takes a new turn The French/US Company who is a global leading actor in prostate cancer fusion biopsy and focal therapy, is proud and happy to announce a growth equity investment by InnovaHealth Partners. Congrats to employees, partners, clients! Download PR (FR) Download PR (EN) We Look Forward […]
Read more >
KOELIS to Present State-of-the-Art Technology
30 April, 2019FollowFollowFollowFollow KOELIS to Present State-of-the-Art Technology at AUA19 KOELIS to Present State-of-the-Art Technology for Precise Prostate Cancer Management at Major Urological Meeting Leading prostate cancer device company to attend the American Urological Association Annual Meeting at booth #2432 Meylan, France and Auburndale, MA, April 29, 2019 – KOELIS, the inventor of Organ-Based Tracking fusion technology […]
Read more >
KOELIS is in the top 10 Medical Imaging Solution Providers 2018!
31 October, 2018FollowFollowFollowFollow KOELIS is in the top 10 Medical Imaging Solution Providers 2018! “Health innovation as a passion” – These are the words that better represents our commitment and passion KOELIS, our mission is to provide clinicians with quality control at every step of the prostate cancer management. We are constantly innovating to bring the most […]
Read more >
KOELIS receives the Bref Eco award for the MIRAS project
14 October, 2018KOELIS awarded Lab Meeting Prize
Read more >
PRECISION Clinical Study confirms Targeted Biopsy combined with Medical Imaging Improves Accuracy and Efficiency of Diagnosis
11 April, 2018FollowFollowFollowFollow PRECISION Clinical Study confirms Targeted Biopsy combined with Medical Imaging Improves Accuracy and Efficiency of Diagnosis Results of the PRECISION international clinical trial published in the New England Journal of Medicine confirm KOELIS’ approach KOELIS announces its contribution to the PRECISION* scientific study, which aims to assess the benefits of Magnetic Resonance Imaging (MRI) […]
Read more >
KOELIS receives the World Innovation Contest Prize for KATTY
9 April, 2018KOELIS receives the World Innovation Contest Prize for KATTY
Read more >
KOELIS and John Hopkins University partnership
15 March, 2018FollowFollowFollowFollow KOELIS and John Hopkins University partnership The prestigious John Hopkins University in Baltimore has entrusted KOELIS in supporting a new clinical research program with state-of-the-art KOELIS Trinity® cartographer and exclusive image fusion technology. Researchers will make use of the precision of the KOELIS system to focus on the application of the F18-Prostate-specific membrane antigen […]
Read more >
IUCT Oncopole evaluates KOELIS transperineal biopsy under LA
15 March, 2018FollowFollowFollowFollow IUCT Oncopole evaluates KOELIS transperineal biopsy under local anesthesia within their clinical routine Pr Malavaud and Dr Portalez from Institut Universitaire du Cancer de Toulouse Oncopole are now using KOELIS Trinity® Perine application under local anesthesia. After having demonstrated this technique is feasible, an evaluation on several patients is ongoing to validate this practice […]
Read more >
KOELIS Trinity® Recfire, available in Canada for targeted transrectal interventions
23 January, 2018KOELIS Trinity®available in Canada
Read more >
Expert meeting about the value of 3D Cartography
23 January, 2018Expert meeting about the value of 3D Cartography for biopsy and treatment in Madrid
Read more >
1st biopsy with Trinity® Recfire at Trabzon Kanuni Research and Training Hospital
19 December, 2017MRI/TRUS fusion-targeted prostate biopsy with Trinity® Recfire has been performed for the first time in Trabzon Kanuni Research and Training Hospital
Read more >
1st KOELIS transrectal biopsy in Israel
26 November, 20171st KOELIS transrectal biopsy in Israel
Read more >
KOELIS at Second Global Summit on Precision Diagnosis for Prostate Cancer
21 November, 2017KOELIS is glad to have participated at the Second Global Summit on Precision Diagnosis for Prostate Cancer
Read more >
World premieres in targeted treatment strategies
21 November, 2017With more than 10 year-experience in developing image-guided surgery solutions, KOELIS takes a step forward in prostate cancer management
Read more >
Dr. Abreu first physician in USA to use KOELIS Trinity® Perine
19 October, 2017Dr. Abreu first physician in USA to use KOELIS Trinity® Perine
Read more >
First transperineal biopsy under local anesthesia
19 October, 2017FollowFollowFollowFollow First transperineal biopsy under local anesthesia 1st Transperineal Biopsy under Local Anesthesia Light and easy-to-manipulate Perine guides and Steady Pro™ probe-holder make transperineal interventions easier and simpler, removing cumbersome steps and enabling them to perform interventions under local anesthesia. Prove of that has been the biopsy performed in Porto during a consultation by Dr. […]
Read more >